| 摘要 |
<p>The following are claimed: (A) use of natural human alpha -interferon for preparation of medicaments in liquid form, to be administered by the peroral route at dosages of 100-500 IU/day, for (i) therapy of viral hepatitis, or (ii) therapy of neoplasia and immunological diseases, in humans and animals; and (B) a pharmaceutical liquid composition for peroral administration, comprising natural human alpha -interferon (either from lymphoblastoid cell cultures or from lymphocyte cells) at a concentration of 100-500 IU/ml. The interferon is obtained from lymphoblastoid cell cultures or from lymphocyte cells. The medicament is administered in monodosage units of approximately 1 ml.</p> |
